Jim Cramer
Facing Tough Questions: Why We’re Downgrading Lilly After the Obesity Pill Setback
Eli Lilly recently reported impressive second-quarter earnings, but its stock price took a significant hit—falling over 14%. This decline raises ... Read more
Microsoft’s Record Quarter and Promising Future: Reinforcing Its Leadership in AI Innovation
Microsoft’s latest earnings report reveals a strong upward trend, mainly in cloud-computing. In the fourth quarter of fiscal 2025, Microsoft ... Read more
Jim Cramer Reveals Why PepsiCo Dominates the Junk Food Market: Insights You Can’t Miss!
PepsiCo, Inc. (NASDAQ: PEP) has been a hot topic lately, especially with insights from Jim Cramer. He highlighted how despite ... Read more
Why We See Opportunity in BlackRock’s 5% Drop After Mixed Earnings — A Buying Opportunity This Wednesday!
BlackRock’s recent earnings report stirred up a mix of investor reactions. The world’s largest asset manager saw its stock dip ... Read more
How Trump’s New Tariff Blitz Faces Off Against a Soaring Stock Market: What You Need to Know
The stock market took a dip recently after President Trump renewed talk about tariffs. This week, he informed various U.S. ... Read more
